The Avoid Stroke As Soon As Possible (ASAP) general practice stroke audit

Medical Journal of Australia

Volumn 176, Issue 7, 2002, Pages 312-316

  Sturm, Jonathan W ^a   Davis, Stephen M ^a   O'Sullivan, John G ^a   Vedadhaghi, Miriam E ^a   Donnan, Geoffrey A ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; WARFARIN;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CASE FINDING; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MULTICENTER STUDY; POPULATION RESEARCH; PREVALENCE; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0036531525     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04430.x     Document Type: Article

References (24)

1. Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study
2. Stroke incidence on the east coast of Australia: The North East Melbourne Stroke Incidence Study (NEMESIS)
3. A long term follow-up of stroke patients
4. Modern management of acute stroke
5. Stroke prevention
6. American Heart Association Prevention Conference IV: Prevention and rehabilitation of stroke: Risk factors
7. Major risk factors and protective factors: How to improve primary prevention of cerebrovascular disease
8. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee
9. Primary prevention of ischemic stroke. A statement for healthcare professionals from the Stroke Council of the American Heart Association
10. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
11. Health outcomes associated with antihypertensive therapies used as first-line agents: A systematic review and meta-analysis
12. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration
13. Drugs and surgery in the prevention of ischaemic stroke
14. Stroke, statins, and cholesterol: A meta-analysis of randomised, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
15. Meta-analysis of relation between cigarette smoking and stroke
16. Analysis of data from trials of salt reduction
17. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension